Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon as an agent against herpes simplex virus.

M Ho1

  • 1Department of Infectious Disease and Microbiology, School of Medicine, Univerity of Pittsburgh, PA 15261.

The Journal of Investigative Dermatology
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

QOMS Another step along the way.

The British journal of oral & maxillofacial surgery·2026
Same author

Diagnostic challenges and treatment outcomes of primary vitreoretinal lymphoma in Hong Kong.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
Same author

Identifying factors associated with post-hospital falls in older patients: a territory-wide cohort study.

Public health·2024
Same author

Tumor resistance to anti-mesothelin CAR-T cells caused by binding to shed mesothelin is overcome by targeting a juxtamembrane epitope.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Comparison of United Kingdom and United States screening criteria for detecting retinopathy of prematurity in Hong Kong.

Hong Kong medical journal = Xianggang yi xue za zhi·2023
Same author

Chinese version Weight-Related Eating Questionnaire to assess psychological aspects of eating behaviours in Chinese adults: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2023

Interferon effectively reduces herpes simplex virus symptoms and viral load when administered early. However, it cannot eliminate latent infections or prevent disease entirely, especially when treatment is delayed.

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Background:

  • Interferon (IFN) is a crucial component of the innate immune system with known antiviral properties.
  • Herpes simplex virus (HSV) types 1 and 2 are common human pathogens causing a range of clinical manifestations.

Purpose of the Study:

  • To evaluate the efficacy and limitations of interferon as an antiviral therapy against herpes simplex virus infections in humans.
  • To explore the potential of interferon in managing other viral diseases.

Main Methods:

  • The study examines the effects of parenteral interferon administration on clinical outcomes and viral yield in herpes simplex virus infections.
  • The research considers the timing of interferon administration relative to infection onset and disease progression.

Related Experiment Videos

Main Results:

  • Parenteral interferon, when given in adequate doses before or shortly after infection, can ameliorate clinical manifestations and reduce viral load.
  • Interferon therapy is generally unable to completely prevent disease and is less effective when administered late in acute infections.
  • Interferon is ineffective against latent herpes simplex virus infections residing in ganglia.

Conclusions:

  • Interferon shows promise in managing acute herpes simplex virus infections by reducing symptoms and viral shedding.
  • The effectiveness of interferon is limited by the inability to eradicate latent infections and its reduced efficacy in late-stage or acute disease.
  • Interferon may hold greater therapeutic potential for slower-progressing viral diseases or conditions where its pleiotropic effects can modulate other pathogenetic mechanisms.